ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MarketBeat Week in Review: 12/25 - 12/29

As the shortened trading week ended, the much-anticipated Santa Claus rally took the S&P 500 up about 0.75%. The takeaway from 2023 will be that many investors expected a recession that never occurred. 

But recession concerns still linger over the economy heading into 2024. The full impact of the Federal Reserve's rate tightening has yet to make its way through the economy. Investors won't have to wait too long to start getting answers. The next earnings season gets underway in early January. 

We wish you and your families health and good fortune as you ring in the New Year. As you prepare to start a new trading year on Tuesday, take some time to review some of the top stocks and stories impacting the market. Here are some of the top stories from this week.  

Articles by Jea Yu 

One of the biggest stories impacting the market in December was US Steel's announcement that it agreed to be acquired by Japan's Nippon Steel. The proposed acquisition is igniting speculation about sector consolidation. This week, Jea Yu explains why Cleveland-Cliffs Inc. (NYSE: CLF) may be the industry's next acquisition target

Yu also wrote about the ongoing artificial intelligence (AI) arms race and how Intel Co. (NYSE: INTC) is announcing its entry into the arena with the launch of its Gaudi3 AI chip

In 2023, buy-now-pay-later (BNPL) has become a way for many consumers to manage the higher cost of goods and services. It caused BNPL stocks like Affirm Holdings Inc. (NASDAQ: AFRM) moved higher. However, Yu explains why investors who got in on AFRM stock early this year may want to take a profit

Articles by Thomas Hughes 

One investment theory that has some historical precedent is the Dogs of the Dow theory. This says that the worst-performing Dow-30 stocks in one year will be among the best performers the following year. This week, Thomas Hughes analyzed the outlook for the three biggest dogs in 2023

Another sound strategy is to invest in stocks that get analysts' upgrades. Hughes looks at three of the most upgraded stocks of 2023 and explains why each is likely to have more upside for investors in 2024. 

Hughes was also writing about Warren Buffett's ongoing purchases of Occidental Petroleum Co. (NYSE: OXY). Hughes defines the price range that marks the "Buffett buy zone," why Buffett is investing heavily in OXY stock and why you may want to do the same. 

Articles by Sam Quirke 

The electric vehicle market did not rev up as much as investors expected in 2023. The high cost of scaling production in a rising interest rate environment will continue to impact many up-and-coming EV makers. But Sam Quirke writes why Rivian Automotive Inc. (NASDAQ: RIVN) is proving to be an exception. With analysts bidding up the stock, the end-of-the-year rally may just be getting started. 

Quirke also explains why investors looking for growth opportunities in 2024 will continue to look at the technology sector. But instead of investing blindly, Quirke suggests looking at tech stocks that recently got bullish upgrades that set the stage for better performance in 2024. 

Articles by Kate Stalter  

Small-cap investors have had a strong two months. However, the best may be yet to come. This week, Kate Stalter wrote why investor optimism for lower interest rates will push small-cap stocks even higher in 2024. 

On the opposite end of the market cap spectrum, Stalter analyzes the year that was for Apple Inc. (NASDAQ: AAPL). As Stalter explains, Apple remains a favorite among institutional investors for many reasons. Still, investors who hold the stock may want to manage their expectations and look for opportunistic pullbacks to add to their position.  

Some analysts predict 2024 will be a good year for biotech and pharmaceutical stocks. If that's the case, Stalter points investors to Bristol Myers Squibb Company (NYSE: BMY), which made two recent acquisitions that will expand its position in areas like neuroscience and oncology. 

Articles by Ryan Hasson 

Ryan Hasson was also writing about biotech stocks. However, unlike Stalter, Hasson was looking at the small-cap biotech stock Liquidia Co. (NASDAQ: LQDA), which is soaring after winning a victory in court

The end of earnings season gives investors time to look at winners versus losers. This week, Hasson points investors toward three tech stocks that are among the sector's biggest winners in 2023 and have plenty of reasons to believe they have more upside to come. 

Hasson also wrote about the recent performance of the Financial Select Sector Fund (NYSE: XLF). Many investors may not be considering financial stocks. Hasson explains why it may be time that you give the sector a closer look. 

Articles by Gabriel Osorio-Mazilli 

Nio Inc. (NYSE: NIO) is one of the stocks that is benefiting the most from the Santa Claus rally. Investors comfortable with the volatility in the electric vehicle (EV) sector will want to read Gabriel Osorio-Mazilli's article explaining why NIO shares spiked over 10% and what it may mean heading into 2024. 

Even with tight inventory and mortgage rates at nearly 20-year highs, the housing market continues to strengthen. But for many reasons, the industry will likely perform well in 2024. Osorio-Mazilli explains why one reason to believe in the housing sector is the heightened interest in Rocket Companies Inc. (NYSE: RKT)

Osorio-Mazilli also analyzed Align Technology Inc. (NASDAQ: ALGN), which retail investors may overlook, but analysts certainly are not

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.22
+1.41 (0.78%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.